Tech Company Financing Transactions
Nxera Pharma Funding Round
On 4/20/2026, Nxera Pharma raised $10 million in funding from AbbVie Biotech Ventures.
Transaction Overview
Company Name
Announced On
4/20/2026
Transaction Type
Debt
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Midtown East, 9-7-2 Akasaka, Minato-ku
Tokyo, 107-0052
Japan
Tokyo, 107-0052
Japan
Phone
Website
Email Address
Not Recorded
Overview
We have a clear vision and commitment to build a successful next-generation, technology driven biopharma company making a difference for patients worldwide. Our Mission: To accelerate the development of life-changing medicines, by investing in science and technology. Our Vision: To lead the next era of medicine. From Japan, for Japan, and by extension, to the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Cargill
Browse more venture capital transactions:
Prev: 4/20/2026: Coral venture capital transaction
Next: 4/20/2026: Jozo venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs